Abstract:SESSION TITLE: Tuesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/22/2019 01:00 PM - 02:00 PM PURPOSE: The aim of this study is to determine if biomarkers can play clinically significant role in the prediction for risk stratification of acute pulmonary embolism (APE). METHODS: Patients diagnosed with APE by computed tomography pulmonary arteriography (CTPA) were enrolled from August 2016 to April 2019 in the prospective, cross-section observational study. Demographic features, clinical manifestations, laboratory data, imaging features and pulmonary embolism severity index (PESI) scores were collected on admission. The patients were divided into high-risk and non-high-risk groups according to 2014 European Society of Cardiology (ESC) guidelines for APE. The differences between the patients in two groups were compared and a predictive model for high risk APE was established using univariate and multivariate logistic regression analyses. The accuracy in predicting the poor outcomes of the patients with APE using these parameters was compared in a Receiver-Operating Characteristic (ROC) plot. RESULTS: A total of 106 patients, 59 males (55.7%), 47 females (44.3%), age range of 20 to 87 years were included whose cohort with the high risk group of 32 cases and the non-high risk group of 74 demonstrated significant differences with higher incidence of underlying pulmonary disease, thrombus burden, frequency of acute exacerbation of chronic obstructive pulmonary disease (COPD), degree of dyspnea, level of systolic pressure, bilateral embolism, PESI score, ratio of neutrophils to lymphocytes (NLR), prothrombin time (PT), lactic acid dehydrogenase (LDH), C-reactive protein (CRP) and serum level of growth and differentiation factor-15 (GDF-15) in the high risk group (p<0.05). GDF-15 (OR=1.022, 95%CI:1.003∼1.041) and LDH (OR=1.041, 95%CI:1.007∼1.076) were independently associated with high-risk of APE in the multivariate logistic regression model. The cut-off values of serum levels of GDF-15 and LDH for APE patients with higher risk were 1017.4 pg/ml and 388.5 U/L and the corresponding sensitivity and specificity were 90.9%, 86.5 % and 68.2%, 97.3% respectively. CONCLUSIONS: Higher serum levels of LDH and GDF-15 at admission increase the risk of APE leading to poor outcomes. The serum levels of LDH and GDF-15 could therefore play a significant role as predictive factors of APE in patients with high risk factors. CLINICAL IMPLICATIONS: APE is a serious clinical condition which can lead to high morbidity and mortality. Risk stratification could predict 30-day mortality in patients with APE, however, further improvements can be achieved using biomarkers. DISCLOSURES: No relevant relationships by aamer Chughtai, source=Web Response no disclosure on file for XIAO GAN; No relevant relationships by Lu Guo, source=Web Response no disclosure on file for YICEN HAN; no disclosure on file for Jingyan Liu; no disclosure on file for shengkun Peng; no disclosure on file for Hong Pu; no disclosure on file for jing zhang; no disclosure on file for Jing Zhang

Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism

Short‐term mortality prediction in acute pulmonary embolism: Radiomics values of skeletal muscle and intramuscular adipose tissue

Utilization of a Novel Scoring System in Predicting 30-day Mortality in Acute Pulmonary Embolism, the CLOT-5 Pilot Study

A Radiological Nomogram to Predict 30-day Mortality in Patients with Acute Pulmonary Embolism

A prognostic prediction model for acute pulmonary embolism

Performance of the Simplified Pulmonary Embolism Severity Index in Predicting 30-Day Mortality after Acute Pulmonary Embolism: Validation from a Large-Scale Cohort.

Evaluation of Four Validated Risk Scores to Predict Outcomes in Hispanic Patients With Acute Pulmonary Embolism

A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score

Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism

Radiomics parameters of epicardial adipose tissue predict mortality in acute pulmonary embolism

Role of serum biomarkers in predicting management strategies for acute pulmonary embolism

Predictive score for in-hospital mortality in patients with severe AECOPD

Computed tomography-based radiomics model to predict adverse clinical outcomes in acute pulmonary embolism

Acute pulmonary embolism: risk stratification in the emergency department

Prediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva Score

Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model

Risk stratification of elderly patients with acute pulmonary embolism

Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models

External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers

Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score)

ROLE OF BIOMARKERS IN PREDICTION FOR RISK STRATIFICATION OF ACUTE PULMONARY EMBOLISM